(Q35871868)

10 August 2017

1 reference

title

An overview of the development of medications including novel anticonvulsants for the treatment of alcohol dependence (English)

1 reference

10 August 2017

Bankole A Johnson

1

1 reference

10 August 2017

language of work or name

English

0 references

publication date

1 September 2004

1 reference

Expert Opinion on Pharmacotherapy

10 August 2017

published in

1 reference

10 August 2017

volume

5

1 reference

10 August 2017

issue

9

1 reference

10 August 2017

page(s)

1943-1955

1 reference

Neurobiology of alcohol abuse

10 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.9.1943

Drugs of abuse: anatomy, pharmacology and function of reward pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.9.1943

Alcoholism: allostasis and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.9.1943

Neuropharmacological treatments for alcoholism: scientific basis and clinical findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.9.1943

Comparing and combining naltrexone and acamprosate in relapse prevention of alcoholism: a double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.9.1943

Neurogenetic adaptive mechanisms in alcoholism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.9.1943

Combining ondansetron and naltrexone reduces craving among biologically predisposed alcoholics: preliminary clinical evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.9.1943

Progress in the development of topiramate for treating alcohol dependence: from a hypothesis to a proof-of-concept study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.9.1943

Addiction and the brain: The neurobiology of compulsion and its persistence

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.9.1943

Psychometric properties and validity of the obsessive-compulsive drinking scale.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.9.1943

Oral topiramate for treatment of alcohol dependence: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.9.1943

The role of laboratory tests in alcoholism treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.9.1943

Current status of carbohydrate deficient transferrin, total serum sialic acid, sialic acid index of apolipoprotein J and serum beta-hexosaminidase as markers for alcohol consumption

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.9.1943

Biochemical detection and monitoring of alcohol abuse and abstinence

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.9.1943

Divalproex sodium (Depakote) for alcohol withdrawal and relapse prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.9.1943

Divalproex sodium in alcohol withdrawal: a randomized double-blind placebo-controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.9.1943

The effects of carbamazepine and lorazepam on single versus multiple previous alcohol withdrawals in an outpatient randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.9.1943

The differential effects of medication on mood, sleep disturbance, and work ability in outpatient alcohol detoxification

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.9.1943

Ondansetron reduces the craving of biologically predisposed alcoholics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.9.1943

Effects of ondansetron in early- versus late-onset alcoholics: a prospective, open-label study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.9.1943

Targeted use of naltrexone without prior detoxification in the treatment of alcohol dependence: a factorial double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.9.1943

Naltrexone vs. nefazodone for treatment of alcohol dependence. A placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.9.1943

The use of divalproex in alcohol relapse prevention: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.9.1943

A double-blind, placebo-controlled pilot study of carbamazepine for the treatment of alcohol dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.9.1943

Topiramate enhances GABA-mediated chloride flux and GABA-evoked chloride currents in murine brain neurons and increases seizure threshold

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.9.1943

Efficacy of Naltrexone and Acamprosate for Alcoholism Treatment: A Meta-Analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.9.1943

10.1517/14656566.5.9.1943

21 January 2018

Identifiers

DOI

1 reference

10 August 2017

1 reference